Previous Close | 26.21 |
Open | 26.25 |
Bid | 26.75 x N/A |
Ask | 27.30 x N/A |
Day's Range | 26.25 - 26.74 |
52 Week Range | 18.11 - 28.16 |
Volume | |
Avg. Volume | 4,568 |
Market Cap | 9.41B |
Beta (5Y Monthly) | 0.48 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.77 |
Earnings Date | Oct 30, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VAUGHAN, Ontario, October 09, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter 2024 financial results on Wednesday, October 30, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the star
VAUGHAN, Ontario, October 01, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Opal, a digital e-commerce marketplace. Designed to help maximize efficiencies for eye care practices while enhancing the patient experience, Opal provides a streamlined ordering process for Bausch + Lomb contact lenses, with select Bausch + Lomb over-the-counter products to be added in the co
Bausch + Lomb Corporation (T.BLCO) hit a new 52-week high of $27.36 Wednesday. No news stories available ...